Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University found treating bacteria with a silver-containing compound boosted the efficacy of a broad range of widely used antibiotics and helped them stop otherwise lethal infections in mice.
It also helped make an antibiotic-resistant strain of bacteria sensitive to antibiotics again. And it expanded the power of an antibiotic called vancomycin that is usually only effective in killing pathogens called Gram-positive bacteria, such as Staph and Strep.
Silver also proved useful for two types of stubborn infections that usually require repeated rounds of antibiotic treatment and multiple visits to the clinic: dormant bacteria that lie low during antibiotic treatment and rebound to cause recurrent infections, and microbial slime layers called biofilms that coat catheters and prosthetic joints.
"The results suggest that silver could be incredibly valuable as an adjunct to existing antibiotic treatments," said Jim Collins, a pioneer of synthetic biology and Core Faculty member at the Wyss Institute.
More From This Section
He found that silver compounds cause bacteria to produce more reactive oxygen species - chemically reactive molecules that damage the bacterial cell's DNA and enzymes, as well as the membrane that encloses the cell.
The results showed that a small amount of silver made E coli bacteria between 10 and 1000 times more sensitive to three commonly used antibiotics: gentamycin, ofloxacin, and ampicillin.
In mice, silver also helped antibiotics fight E coli-induced urinary-tract infections. It made a previously impervious strain of E coli sensitive to the antibiotic tetracycline.
The scientists also found that the doses of silver needed to help antibiotics did not harm cultured human cells, suggesting that oral and injectable silver could be safe for humans as well.
The study was published in Science Translational Medicine.